Abivax (ABVX) Goodwill & Intangibles (2021 - 2026)
Abivax (ABVX) recorded quarterly Goodwill & Intangibles of $29.3 million in Q1 2026, up 0.58% quarter-over-quarter from $29.1 million in Q4 2025, and up 11.3% on a YoY basis from $26.3 million in Q1 2025.
Abivax (ABVX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Abivax's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $29.3 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 11.3% year-over-year to $29.3 million; the TTM figure through Mar 2026 stood at $29.3 million (up 11.3% YoY), while the FY2025 annual figure was $29.1 million, up 8.93% from the prior year.
- Goodwill & Intangibles was $29.3 million for Q1 2026 at Abivax, up from $29.1 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $29.3 million in Q1 2026 to a low of $25.5 million in Q4 2022.
- Historically, Goodwill & Intangibles has averaged $27.6 million across 5 years, with a median of $27.0 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 23899.32% in 2022, then dropped 0.67% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $25.5 million in 2022, then climbed by 5.45% to $26.9 million in 2023, then declined by 0.67% to $26.7 million in 2024, then rose by 8.93% to $29.1 million in 2025, then gained by 0.58% to $29.3 million in 2026.
- The last three Goodwill & Intangibles figures came in at $29.3 million (Q1 2026), $29.1 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.30 Mn |
| Dec 31, 2025 | 29.13 Mn |
| Sep 30, 2025 | 29.26 Mn |
| Jun 30, 2025 | 28.33 Mn |
| Mar 31, 2025 | 26.32 Mn |
| Dec 31, 2024 | 26.74 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Dec 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 25.53 Mn |
| Dec 31, 2021 | 106,389.30 |